114 related articles for article (PubMed ID: 8932332)
1. Aromatase cytochrome P450 gene expression in endometrial carcinoma.
Sasano H; Kaga K; Sato S; Yajima A; Nagura H; Harada N
Br J Cancer; 1996 Nov; 74(10):1541-4. PubMed ID: 8932332
[TBL] [Abstract][Full Text] [Related]
2. CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors.
Bulun SE; Economos K; Miller D; Simpson ER
J Clin Endocrinol Metab; 1994 Dec; 79(6):1831-4. PubMed ID: 7989490
[TBL] [Abstract][Full Text] [Related]
3. Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction.
Zhou C; Zhou D; Esteban J; Murai J; Siiteri PK; Wilczynski S; Chen S
J Steroid Biochem Mol Biol; 1996 Oct; 59(2):163-71. PubMed ID: 9010331
[TBL] [Abstract][Full Text] [Related]
4. Aromatase in human common epithelial ovarian neoplasms.
Kaga K; Sasano H; Harada N; Ozaki M; Sato S; Yajima A
Am J Pathol; 1996 Jul; 149(1):45-51. PubMed ID: 8686761
[TBL] [Abstract][Full Text] [Related]
5. Aromatase expression in stromal cells of endometrioid endometrial cancer correlates with poor survival.
Segawa T; Shozu M; Murakami K; Kasai T; Shinohara K; Nomura K; Ohno S; Inoue M
Clin Cancer Res; 2005 Mar; 11(6):2188-94. PubMed ID: 15788666
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of aromatase in breast cancer tissues.
Harada N
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):175-84. PubMed ID: 9365188
[TBL] [Abstract][Full Text] [Related]
7. Aromatase and comparative response to its inhibitors in two types of endometrial cancer.
Berstein L; Kovalevskij A; Zimarina T; Maximov S; Gershfeld E; Vasilyev D; Baisheva S; Baymakhasheva A; Thijssen JH
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):71-4. PubMed ID: 15939586
[TBL] [Abstract][Full Text] [Related]
8. Quantitative detection of alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in aromatase-expressing human cells by competitive RT-PCR.
Agarwal VR; Bulun SE; Simpson ER
Mol Cell Probes; 1995 Dec; 9(6):453-64. PubMed ID: 8808317
[TBL] [Abstract][Full Text] [Related]
9. Presence of alternatively spliced transcripts of aromatase gene in human breast cancer.
Utsumi T; Harada N; Maruta M; Takagi Y
J Clin Endocrinol Metab; 1996 Jun; 81(6):2344-9. PubMed ID: 8964875
[TBL] [Abstract][Full Text] [Related]
10. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
[TBL] [Abstract][Full Text] [Related]
11. Aromatase in hyperplasia and carcinoma of the human prostate.
Hiramatsu M; Maehara I; Ozaki M; Harada N; Orikasa S; Sasano H
Prostate; 1997 May; 31(2):118-24. PubMed ID: 9140125
[TBL] [Abstract][Full Text] [Related]
12. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma.
Utsunomiya H; Ito K; Suzuki T; Kitamura T; Kaneko C; Nakata T; Niikura H; Okamura K; Yaegashi N; Sasano H
Clin Cancer Res; 2004 Sep; 10(17):5850-6. PubMed ID: 15355916
[TBL] [Abstract][Full Text] [Related]
13. Aromatase in atherosclerotic lesions of human aorta.
Murakami H; Harada N; Sasano H
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):67-74. PubMed ID: 11850209
[TBL] [Abstract][Full Text] [Related]
14. Multiple splicing events involved in regulation of human aromatase expression by a novel promoter, I.6.
Shozu M; Zhao Y; Bulun SE; Simpson ER
Endocrinology; 1998 Apr; 139(4):1610-7. PubMed ID: 9528941
[TBL] [Abstract][Full Text] [Related]
15. Polymerase chain reaction amplification fails to detect aromatase cytochrome P450 transcripts in normal human endometrium or decidua.
Bulun SE; Mahendroo MS; Simpson ER
J Clin Endocrinol Metab; 1993 Jun; 76(6):1458-63. PubMed ID: 7684741
[TBL] [Abstract][Full Text] [Related]
16. Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women.
Agarwal VR; Ashanullah CI; Simpson ER; Bulun SE
J Clin Endocrinol Metab; 1997 Jan; 82(1):70-4. PubMed ID: 8989235
[TBL] [Abstract][Full Text] [Related]
17. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral aromatase in human breast, endometrial, and ovarian malignancies.
Sasano H; Harada N
Endocr Rev; 1998 Oct; 19(5):593-607. PubMed ID: 9793759
[TBL] [Abstract][Full Text] [Related]
19. Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies.
Watanabe K; Sasano H; Harada N; Ozaki M; Niikura H; Sato S; Yajima A
Am J Pathol; 1995 Feb; 146(2):491-500. PubMed ID: 7856758
[TBL] [Abstract][Full Text] [Related]
20. Expression of the gene encoding aromatase cytochrome P450 (CYP19) in fetal tissues.
Toda K; Simpson ER; Mendelson CR; Shizuta Y; Kilgore MW
Mol Endocrinol; 1994 Feb; 8(2):210-7. PubMed ID: 8170477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
